Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Nonarteritic anterior ischemic optic neuropathy with PDE-5 inhibitors for erectile dysfunction

International Journal of Impotence Research volume 20, pages 537–543 (2008)Cite this article

Abstract

Phosphodiesterase type-5 (PDE-5) inhibitors are well tolerated and efficacious treatments for male erectile dysfunction that currently rank among the best-selling drugs worldwide. Since their introduction 10 years ago, there have been a number of reports of patients developing, within hours of PDE-5 inhibitor use, permanent visual loss due to nonarteritic anterior ischemic optic neuropathy (NAION), a common optic neuropathy that results from ischemia of the optic nerve head. In some of the cases, visual loss recurred upon rechallenge with the drug. However, as the bulk of the evidence suggesting a relationship between PDE-5 inhibitor use and NAION comes from case reports and small series, it is difficult to ascertain if a cause–effect relationship truly exists. In this paper, following a review of the transient visual side effects of PDE-5 inhibitors and NAION, we discuss the evidence for and against NAION occurring as a complication of PDE-5 inhibitor use.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Fink HA, MacDonald R, Rutks IR, Nelson DB, Wilt TJ . Sildenafil for male erectile dysfunction: a systematic review and meta-analysis. Arch Intern Med 2002; 162: 1349–1360.

    Article  CAS  PubMed  Google Scholar 

  2. Boolell M, Allen MJ, Ballard SA, Gepi-Attee S, Muirhead GJ, Naylor AM et al. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res 1996; 8: 47–52.

    CAS  PubMed  Google Scholar 

  3. McVary KT . Erectile dysfunction. N Engl J Med 2007; 357: 2472–2481.

    Article  CAS  PubMed  Google Scholar 

  4. Marmor MF, Kessler R . Sildenafil (Viagra) and ophthalmology. Surv Ophthalmol 1999; 44: 153–162.

    Article  CAS  PubMed  Google Scholar 

  5. Laties A, Zrenner E . Viagra (sildenafil citrate) and ophthalmology. Prog Retin Eye Res 2002; 21: 485–506.

    Article  CAS  PubMed  Google Scholar 

  6. Cote RH . Characteristics of photoreceptor PDE (PDE6): similarities and differences to PDE5. Int J Impot Res 2004; 16 (Supp 1): S28–S33.

    Article  CAS  PubMed  Google Scholar 

  7. Jägle H, Jägle C, Sérey L, Yu A, Rilk A, Sadowski B et al. Visual short-term effects of Viagra: double-blind study in healthy young subjects. Am J Ophthalmol 2004; 137: 842–849.

    Article  PubMed  Google Scholar 

  8. Luu JK, Chappelow AV, McCulley TJ, Marmor MF . Acute effects of sildenafil on the electroretinogram and multifocal electroretinogram. Am J Ophthalmol 2001; 132: 388–394.

    Article  CAS  PubMed  Google Scholar 

  9. McCulley TJ, Lam BL, Marmor MF, Hoffman KB, Luu JK, Feuer WJ . Acute effects of sildenafil (Viagra) on blue-on-yellow and white-on-white Humphrey perimetry. J Neuroophthalmol 2000; 20: 227–228.

    Article  CAS  PubMed  Google Scholar 

  10. Ermis SS, Inan UU, Samli M, Ozturk F . Acute effects of sildenafil on Humphrey visual field and intraocular pressure. Int Ophthalmol 2004; 25: 69–72.

    Article  PubMed  Google Scholar 

  11. Oner HF, Aslan G, Kurtulan E, Uçar T, Saatçi OA, Esen AA . Effect of sildenafil citrate on retinal functions: preliminary report on Humphrey visual field analysis. Urol Int 2004; 73: 28–30.

    Article  PubMed  Google Scholar 

  12. Dryja TP, Rucinski DE, Chen SH, Berson EL . Frequency of mutations in the gene encoding the alpha subunit of rod cGMP-phosphodiesterase in autosomal recessive retinitis pigmentosa. Invest Ophthalmol Vis Sci 1999; 40: 1859–1865.

    CAS  PubMed  Google Scholar 

  13. Behn D, Potter MJ . Sildenafil-mediated reduction in retinal function in heterozygous mice lacking the γ-subunit of phosphodiesterase. Invest Ophthalmol Vis Sci 2001; 42: 523–527.

    CAS  PubMed  Google Scholar 

  14. Rucker JC, Biousse V, Newman NJ . Ischemic optic neuropathies. Curr Opin Neurol 2004; 17: 27–35.

    Article  PubMed  Google Scholar 

  15. Johnson LN, Arnold AC . Incidence of nonarteritic and arteritic anterior ischemic optic neuropathy. Population-based study in the state of Missouri and Los Angeles County, California. J Neuroophthalmol 1994; 14: 38–44.

    Article  CAS  PubMed  Google Scholar 

  16. Hattenhauer MG, Leavitt JA, Hodge DO, Grill R, Gray DT . Incidence of nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1997; 123: 103–107.

    Article  CAS  PubMed  Google Scholar 

  17. Hayreh SS . Anterior ischaemic optic neuropathy: differentiation of arteritic from non-arteritic type and its management. Eye 1990; 4: 25–41.

    Article  PubMed  Google Scholar 

  18. Ischemic Optic Neuropathy Decompression Trial Research Group. Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the ischemic optic neuropathy decompression trial. Arch Ophthalmol 1996; 114: 1366–1374.

    Article  Google Scholar 

  19. Arnold AC . Pathogenesis of nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol 2003; 23: 157–163.

    Article  PubMed  Google Scholar 

  20. Hayreh SS, Podhajsky PA, Zimmerman B . Non-arteritic anterior ischemic optic neuropathy: time of onset of visual loss. Am J Ophthalmol 1997; 124: 641–647.

    Article  CAS  PubMed  Google Scholar 

  21. Hayreh SS, Zimmerman MB, Podhajsky PA, Alward WL . Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol 1994; 117: 603–624.

    Article  CAS  PubMed  Google Scholar 

  22. Beck RW, Servais GE, Hayreh SS . Anterior ischemic optic neuropathy. IX. Cup-to-disc ratio and its role in pathogenesis. Ophthalmology 1987; 94: 1503–1508.

    Article  CAS  PubMed  Google Scholar 

  23. Chi T, Ritch R, Stickler D, Pitman B, Tsai C, Hsieh FY . Racial differences in optic nerve head parameters. Arch Ophthalmol 1989; 107: 836–839.

    Article  CAS  PubMed  Google Scholar 

  24. Ischemic Optic Neuropathy Decompression Trial Research Group. Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. JAMA 1995; 273: 625–632.

    Article  Google Scholar 

  25. Newman NJ, Scherer R, Langenberg P, Kelman S, Feldon S, Kaufman D, et al., Ischemic Optic Neuropathy Decompression Trial Research Group. The fellow eye in NAION: report from the ischemic optic neuropathy decompression trial follow-up study. Am J Ophthalmol 2002; 134: 317–328.

    Article  PubMed  Google Scholar 

  26. Cunningham AV, Smith KH . Anterior ischemic optic neuropathy associated with Viagra. J Neuroophthalmol 2001; 21: 22–25.

    Article  CAS  PubMed  Google Scholar 

  27. Pomeranz HD, Smith KH, Hart WM, Egan RA . Sildenafil-associated nonarteritic anterior ischemic optic neuropathy. Ophthalmology 2002; 109: 584–587.

    Article  PubMed  Google Scholar 

  28. Dheer S, Rekhi GS, Merlyn S . Sildenafil associated anterior ischemic optic neuropathy. J Assoc Physicians India 2002; 50: 265.

    PubMed  Google Scholar 

  29. Boshier A, Pambakian N, Shakir SA . A case of nonarteritic ischemic optic neuropathy (NAION) in a male patient taking sildenafil. Int J Clin Pharmacol Ther 2002; 40: 422–423.

    Article  CAS  PubMed  Google Scholar 

  30. Gruhn N, Fledelius HC . Unilateral optic neuropathy associated with sildenafil intake. Acta Ophthalmol Scand 2005; 83: 131–132.

    Article  PubMed  Google Scholar 

  31. Sinha S, Pathak-Ray V, Ahluwalia H, Morgan JE . Viagra or what? Eye 2004; 18: 446–448.

    Article  CAS  PubMed  Google Scholar 

  32. Pomeranz HD, Bhavsar AR . Nonarteritic ischemic optic neuropathy developing soon after use of sildenafil (Viagra): a report of seven new cases. J Neuroophthalmol 2005; 25: 9–13.

    Article  PubMed  Google Scholar 

  33. Escaravage Jr GK, Wright JD, Givre SJ . Tadalafil associated with anterior ischemic optic neuropathy. Arch Ophthalmol 2005; 123: 399–400.

    Article  PubMed  Google Scholar 

  34. Bollinger K, Lee MS . Recurrent visual field defect and ischemic optic neuropathy associated with tadalafil rechallenge. Arch Ophthalmol 2005; 123: 400–401.

    Article  PubMed  Google Scholar 

  35. Peter NM, Singh MV, Fox PD . Tadalafil-associated anterior ischaemic optic neuropathy. Eye 2005; 19: 715–717.

    Article  CAS  PubMed  Google Scholar 

  36. Akash R, Hrishikesh D, Amith P, Sabah S . Case report: association of combined nonarteritic anterior ischemic optic neuropathy (NAION) and obstruction of cilioretinal artery with overdose of Viagra. J Ocul Pharmacol Ther 2005; 21: 315–317.

    Article  CAS  PubMed  Google Scholar 

  37. Gedik S, Yilmaz G, Akova YA . Sildenafil-associated consecutive nonarteritic anterior ischemic optic neuropathy, cilioretinal artery occlusion, and central retinal vein occlusion in a hemodialysis patient. Eye 2007; 21: 129–130.

    Article  CAS  PubMed  Google Scholar 

  38. Sivaswamy L, Vanstavern GP . Ischemic optic neuropathy in a child. Pediatr Neurol 2007; 37: 371–372.

    Article  PubMed  Google Scholar 

  39. Sowka JW, Neiberg MN, Vollmer LA . Optic atrophy after sildenafil use. Optometry 2007; 78: 122–128.

    Article  PubMed  Google Scholar 

  40. Pepin S, Pitha-Rowe I . Stepwise decline in visual field after serial sildenafil use. J Neuroophthalmol 2008; 28: 76–77.

    Article  PubMed  Google Scholar 

  41. McGwin Jr G, Vaphiades MS, Hall TA, Owsley C . Non-arteritic anterior ischaemic optic neuropathy and the treatment of erectile dysfunction. Br J Ophthalmol 2006; 90: 154–157.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Sobel RE, Cappelleri JC . NAION and treatment of erectile dysfunction: reply from Pfizer. Br J Ophthalmol 2006; 90: 927.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Danesh-Meyer HV, Levin LA . Erectile dysfunction drugs and risk of anterior ischaemic optic neuropathy: casual or causal association? Br J Ophthalmol 2007; 91: 1551–1555.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Margo CE, French DD . Ischemic optic neuropathy in male veterans prescribed phosphodiesterase-5 inhibitors. Am J Ophthalmol 2007; 143: 538–539.

    Article  CAS  PubMed  Google Scholar 

  45. Reffelmann T, Kloner RA . Cardiovascular effects of phosphodiesterase 5 inhibitors. Curr Pharm Des 2006; 12: 3485–3494.

    Article  CAS  PubMed  Google Scholar 

  46. Hayreh SS . Erectile dysfunction drugs and non-arteritic anterior ischemic optic neuropathy: is there a cause and effect relationship. J Neuroophthalmol 2005; 25: 295–298.

    Article  PubMed  Google Scholar 

  47. Pomeranz HD . Can erectile dysfunction drug use lead to ischaemic optic neuropathy? Br J Ophthalmol 2006; 90: 127–128.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Grunwald JE, Siu KK, Jacob SS, Dupont J . Effect of sildenafil citrate (Viagra) on the ocular circulation. Am J Ophthalmol 2001; 131: 751–755.

    Article  CAS  PubMed  Google Scholar 

  49. Hayreh SS . Comment on: effect of sildenafil citrate (Viagra) on the ocular circulation. Am J Ophthalmol 2002; 133: 169–170.

    Article  Google Scholar 

  50. Petrig BL, Riva CE, Hayreh SS . Laser Doppler flowmetry and optic nerve head blood flow. Am J Ophthalmol 1999; 127: 413–425.

    Article  CAS  PubMed  Google Scholar 

  51. Gorkin L, Hvidsten K, Sobel RE, Siegel R . Sildenafil citrate use and the incidence of nonarteritic ischemic optic neuropathy. Int J Clin Pract 2006; 60: 500–503.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Hatzimouratidis K, Hatzichristou D . Phosphodiesterase type 5 inhibitors: the day after. Eur Urol 2007; 51: 75–88.

    Article  CAS  PubMed  Google Scholar 

  53. http://www.fda.gov/cder/drug/InfoSheets/HCP/sildenafilHCP.htm.

  54. Carter JE . Anterior ischemic optic neuropathy and stroke with use of PDE-5 inhibitors for erectile dysfunction: cause or coincidence? J Neurol Sci 2007; 262: 89–97.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Division of Neuro-Ophthalmology, University Hospitals Case Medical Center, Cleveland, OH, USA

    M J Thurtell & R L Tomsak

Authors
  1. M J Thurtell
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R L Tomsak
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M J Thurtell.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thurtell, M., Tomsak, R. Nonarteritic anterior ischemic optic neuropathy with PDE-5 inhibitors for erectile dysfunction. Int J Impot Res 20, 537–543 (2008). https://doi.org/10.1038/ijir.2008.25

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijir.2008.25

Keywords

This article is cited by

Search

Advanced search

Quick links